UCL Technology Fund Holds 2018 Showcase Event
Lucy Tuffin2018-07-30T13:46:24+01:00On Thursday 3rd May, the UCL Technology Fund hosted a showcase event, in celebration of the first two years of the £50 million fund. Co-managed by UCLB a [...]
Global University Venturing Awards Orchard Therapeutics Deal of the Year Award
Lucy Tuffin2018-05-23T15:25:01+01:00Global University venturing has awarded the 2018 Deal of the Year Award to UCLB spinout, Orchard Therapeutics; a biotechnology company dedicated to transforming [...]
UCL Technology Fund and UK Innovation & Science Seed Fund invest in cell therapy company Glialign
Lucy Tuffin2018-05-03T11:30:16+01:00The UCL Technology Fund (UCLTF), UK Innovation & Science Seed Fund (UKI2S), alongside support from Innovate UK, have invested in UCL spinout company [...]
UCLB Spin out Hazy, wins Microsoft Innovate AI competition
Lucy Tuffin2018-05-02T09:36:57+01:00Hazy (formerly Anon AI), one of our spin out companies, has won this year’s Microsoft Innovate AI competition. The award highlights start-ups harnessing the pow [...]
UCLB spinout Orchard Therapeutics acquires rare disease gene therapy portfolio from GSK
Lucy Tuffin2018-04-12T15:26:38+01:00Today, the clinical-stage gene therapy company, announced its recent strategic agreement with GSK, to acquire its portfolio of approved and investigational rare [...]
Intrinsic launches new website
Lucy Tuffin2018-03-01T11:49:58+01:00UCL spinout company, Intrinsic, launched its new website today. Intrinsic was established to commercialise the novel memristive RRAM devices developed by Prof T [...]
Wired highlights Chirp’s sound-based technology
Lucy Tuffin2018-01-12T16:21:38+01:00Wired’s Klint Finley discusses some of the benefits that sound-based technology can provide to today’s businesses. With wireless technology being so commonly us [...]
UCL spinout company Puridify Limited has been acquired by GE Healthcare
emmaadmin2017-11-30T16:16:10+01:00UCL spinout company, Puridify Limited, developers of bioprocessing technologies to significantly advance industrial biomolecule manufacture has been acquired by [...]
Autolus secures US$80 million series C funding
Matt Peake2017-10-03T09:25:18+01:00Proceeds will be used to establish clinical proof of concept for three novel haematological cancer programs UCL Business spinout company, Autolus Limited, a cli [...]
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Matt Peake2017-09-21T09:58:18+01:00• The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development • Speaking from the W [...]